C81 ROLE OF RESTRICTIVE DIASTOLIC DYSFUNCTION FOR RISK STRATIFICATION OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: A BAYESIAN MODEL AVERAGING
نویسندگان
چکیده
Abstract Background Hypertrophic cardiomyopathy (HCM) is characterized by increased left ventricular (LV) stiffness, leading to raised filling pressures and restrictive diastolic dysfunction (RDD), in itself independently associated with an risk of a clinical deterioration. We assessed whether echocardiography evaluation function HCM could yield prognostic value be useful stratification. Methods retrospectively reviewed imaging (echocardiography cardiovascular magnetic resonance, CMR) data from 361 consecutive patients two Italian referral centers (Mauriziano Hospital, Turin; University Hospital Trieste, Trieste). Among them, 28 were classified after Doppler examination as (E/A > 1.5, DecT E < 140 ms, E/e’ 10). The primary endpoint was large composite consisting sudden cardiac death (SCD), major arrythmias (MVAs), heart transplant (HT) hospitalization for failure (HF). Other secondary endpoints investigated follows: 1) arrhythmic SCD MVAs, 2) key HF, HT, non–SCD. A Bayesian Model Averaging (BMA) then performed overcome the bias determined limited number observations. Results Over mean follow up 7 ± 3 years, 61 (17%) experienced at least one event. Of 10 identified pattern. When BMA performed, late gadolinium enhancement (LGE) presence CMR RDD significantly outcome (respectively, PI = 100, HR 3.55, pd 1.00; 74.5, 3.33, 0.99). Left atrium (LA) diameter not strongly endpoint, whereas it outcome, well (E/e’) 94.5, 1.10, 86.8, 1.08, Conclusions Restrictive independent predictor poor prognosis early stages absence systolic dysfunction. In particular, predicted outcomes related better LA E/e’.
منابع مشابه
Hypertrophic cardiomyopathy and diastolic dysfunction.
Hypertrophic cardiomyopathy (HCM) is a disease state with characteristic pathologic changes most likely to result in abnormalities of diastolic function. Indeed, HCM may well be considered a “poster child” for diastolic dysfunction, because pronounced ventricular hypertrophy is associated with a reduced left ventricular (LV) cavity. The pressurevolume relationship would almost certainly be shif...
متن کاملDiastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
AIMS Several mutations in the ventricular myosin regulatory light chain (RLC) were identified to cause familial hypertrophic cardiomyopathy (FHC). Based on our previous cellular findings showing delayed calcium transients in electrically stimulated intact papillary muscle fibres from transgenic Tg-R58Q and Tg-N47K mice and, in addition, prolonged force transients in Tg-R58Q fibres, we hypothesi...
متن کاملinvestigating the feasibility of a proposed model for geometric design of deployable arch structures
deployable scissor type structures are composed of the so-called scissor-like elements (sles), which are connected to each other at an intermediate point through a pivotal connection and allow them to be folded into a compact bundle for storage or transport. several sles are connected to each other in order to form units with regular polygonal plan views. the sides and radii of the polygons are...
Adiponectin acts as a positive indicator of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy.
BACKGROUND Adiponectin is an adipose-derived plasma protein that exhibits beneficial actions on the heart. Recently, it was shown that adiponectin levels were elevated in patients with systolic heart failure. OBJECTIVE To investigate the association between adiponectin levels and left ventricular (LV) diastolic function in patients with hypertrophic cardiomyopathy (HCM), characterised by dias...
متن کاملHypertrophic cardiomyopathy: diagnosis, risk stratification and treatment.
mon inherited cardiomyopathy, occurring in about 1 in 500 individuals. The first gene mutation for this condition was identified in a large French Canadian family cohort in 1989. Clinical presentation typically includes left ventricular hypertrophy in the absence of abnormal loading conditions, such as hypertension or aortic stenosis. Hypertrophic cardiomyopathy has come to public recognition i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal Supplements
سال: 2023
ISSN: ['1520-765X', '1554-2815']
DOI: https://doi.org/10.1093/eurheartjsupp/suad111.079